Charles River Laboratories International (CRL)

-
Sell: $167.10|Buy: $184.43|Change: 2.69 (1.53%)

Company profile

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Address

251 Ballardvale Street
Wilmington
MA
USA
01887


Telephone

+1 781 2226000


Sector 

Healthcare


Previous key dates

NameKey Date
Barclays 28th Annual Global Healthcare Conference2026-03-10T10:00:00
TD Cowen 46th Annual Health Care Conference2026-03-03T09:50:00
Charles River Laboratories International Inc Fourth Quarter Earnings Conference Call for 20252026-02-18T08:30:00
Charles River Laboratories International Inc Fourth Quarter Earnings Result for 20252026-02-18T00:00:00
Charles River Laboratories International Inc Annual Report for 20252026-02-18T00:00:00
J.P. Morgan Healthcare Conference2026-01-13T10:30:00
Charles River Laboratories to Present at Evercore Healthcare Conference2025-12-03T10:00:00
Jefferies Global Healthcare Conference2025-11-18T06:30:00
Charles River Laboratories International Inc Third Quarter Earnings Conference Call for 20252025-11-05T09:00:00
Charles River Laboratories International Inc Third Quarter Earnings Results for 20252025-11-05T00:00:00
Baird 2025 Global Healthcare Conference2025-09-10T09:40:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-09T10:00:00
Charles River Laboratories International Inc Second Quarter Earnings Conference Call for 20252025-08-06T09:00:00
Charles River Laboratories International Inc Second Quarter Earnings Results for 20252025-08-06T00:00:00
Charles River Laboratories International Inc Annual General Meeting for 20252025-05-20T08:00:00
Bank of America Health Care Conference2025-05-14T08:40:00
Charles River Laboratories International Inc First Quarter Earnings Conference Call for 20252025-05-07T09:00:00
Charles River Laboratories International Inc First Quarter Earnings Result for 20252025-05-07T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.